Aquestive Therapeutics Inc’s recently made public that its Chief Innovation/Tech Officer Schobel Alexander Mark unloaded Company’s shares for reported $0.3 million on Mar 15 ’24. In the deal valued at $6.00 per share,50,000 shares were sold. As a result of this transaction, Schobel Alexander Mark now holds 984,476 shares worth roughly $3.45 million.
Then, Schobel Alexander Mark sold 25,000 shares, generating $129,685 in total proceeds. Upon selling the shares at $5.19, the Chief Innovation/Tech Officer now owns 1,040,371 shares.
Piper Sandler initiated its Aquestive Therapeutics Inc [AQST] rating to an Overweight in a research note published on April 11, 2024; the price target was $10. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in late March with a ‘”an Outperform”‘ rating. H.C. Wainwright started covering the stock on April 22, 2019. It rated AQST as “a Buy”.
Price Performance Review of AQST
On Monday, Aquestive Therapeutics Inc [NASDAQ:AQST] saw its stock fall -0.57% to $3.50. Over the last five days, the stock has lost -6.29%. Aquestive Therapeutics Inc shares have risen nearly 73.27% since the year began. Nevertheless, the stocks have risen 78.57% over the past one year. While a 52-week high of $6.23 was reached on 03/18/24, a 52-week low of $1.25 was recorded on 01/02/24. SMA at 50 days reached $4.24, while 200 days put it at $2.52. A total of 1.06 million shares were traded, compared to the trading of 1.68 million shares in the previous session.
Levels Of Support And Resistance For AQST Stock
The 24-hour chart illustrates a support level at 3.41, which if violated will result in even more drops to 3.31. On the upside, there is a resistance level at 3.60. A further resistance level may holdings at 3.69. The Relative Strength Index (RSI) on the 14-day chart is 41.75, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.27%. Stochastics %K at 25.23% indicates the stock is a holding.
The most recent change occurred on January 03, 2019 when Lake Street began covering the stock and recommended ‘”a Buy”‘ rating along with a $14 price target.
